Anti-ERK2 抗体
Anti-ERK2 antibody
Be the first to review this product! Submit a review
|
(15 Publications)
Rabbit Polyclonal ERK2 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 15 publications.
別名を表示する
Erk2, Mapk, Prkm1, Mapk1, Mitogen-activated protein kinase 1, MAP kinase 1, MAPK 1, ERT1, Extracellular signal-regulated kinase 2, MAP kinase isoform p42, Mitogen-activated protein kinase 2, ERK-2, p42-MAPK, MAP kinase 2, MAPK 2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ERK2 antibody (AB15282)
ab15282, at 1/200 dilution, staining ERK2 in breast carcinoma by IHC-P.
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ERK2 influences several key cellular functions. It functions as part of a signaling cascade transmitting signals from the exterior to the cell nucleus. In this cascade ERK2 is often part of a multi-protein complex that undergoes sequential phosphorylation. Through these mechanisms ERK2 regulates gene expression and is a pivotal component of the MAPK/ERK pathway ensuring the proper response to growth signals and stress stimuli.
Pathways
ERK2 is a central component of the MAPK/ERK signaling pathway and the PI3K/AKT pathway. These pathways play critical roles in cell cycle regulation and apoptosis. ERK2 activation leads to its interaction with the MEK1/2 proteins which further allows the transmission of mitogenic signals. The interplay between ERK2 and related proteins like E460 often impacts cellular growth and development as it precisely controls the phosphorylation events within the pathway.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (15)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine reports 25: PubMed35211757
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Methods & clinical development 22:15-25 PubMed34401402
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 35:109022 PubMed33882303
2021
Applications
Unspecified application
Species
Unspecified reactive species
Translational vision science & technology 9:18 PubMed33117609
2020
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 61:24 PubMed32531058
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cells 9: PubMed32290532
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American So 28:830-844 PubMed32027843
2020
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 33:10177-10192 PubMed31199887
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 27:1712-1725.e6 PubMed31067458
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American So 27:1313-1326 PubMed31043342
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com